TH8676B - Pharmaceutical constituents used in the treatment of glaucoma - Google Patents
Pharmaceutical constituents used in the treatment of glaucomaInfo
- Publication number
- TH8676B TH8676B TH9301000864A TH9301000864A TH8676B TH 8676 B TH8676 B TH 8676B TH 9301000864 A TH9301000864 A TH 9301000864A TH 9301000864 A TH9301000864 A TH 9301000864A TH 8676 B TH8676 B TH 8676B
- Authority
- TH
- Thailand
- Prior art keywords
- glaucoma
- ethyl
- treat glaucoma
- stated
- sulfoamide
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title claims abstract 8
- 239000000470 constituent Substances 0.000 title 1
- -1 5-[1-hydroxy- 2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzene sulfoamide Chemical compound 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000003885 eye ointment Substances 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Abstract
องค์ประกอบทางเภสัชใช้รักษาโรคต้อหิน ซึ่งมีสารออกฤทธิ์ 5-[1-ไฮดรอกซี่- 2-[2-(2-เมทอกซี่ฟีนอกซี่)เอทิลอามิโน]เอทิล]-2-เมทิลเบนซีนซัลโฟอาไมด์ที่มีสูตรดังนี้ (สูตรเคมี) หรือเกลือของมันองค์ประกอบที่ไม่มีผลข้างเคียงมีความเสถียรและสามารถออกฤทธิ์ ลดความดันในลูกตา ที่ได้ปรับปรุงแล้ว มีความเข้มข้นต่ำ: สิทธิบัตรยา The pharmacological component is used to treat glaucoma. which has an active ingredient 5-[1-hydroxy- 2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzene sulfoamide with the following formula (chemical formula ) or its salts, the composition has no side effects, is stable and active. reduce intraocular pressure updated Low Concentration: Patent Medicine
Claims (4)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH13559A TH13559A (en) | 1993-12-15 |
| TH8676B true TH8676B (en) | 1998-12-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94046143A (en) | Pharmaceutical composition for glaucoma treatment | |
| US6355684B1 (en) | Antimicrobial treatment for herpes simplex virus and other infectious diseases | |
| EA199900773A1 (en) | ANTI-MICROBIAL PREVENTION AND TREATMENT OF DISEASES CAUSED BY THE VIRUS OF HUMAN IMMUNODEFICIENCY AND OTHER INFECTIONS | |
| KR900015722A (en) | Pharmaceutical composition containing N- (3,4-dimethoxycinnamoyl) anthranilic acid | |
| DE3872029T2 (en) | RECTALLY ABSORBABLE SHAPE OF L-DOPA. | |
| ATE109149T1 (en) | 3-PYRROLIDINYLTHIO-1-AZABICYCLO(3.2.0>-HEPT-2-E - 2-CARBONIC ACID COMPOUNDS. | |
| EP2002841A1 (en) | Ophthalmic composition comprising xanthan gum and glucose | |
| JPH1160505A (en) | Antiseptic composition | |
| KR100260061B1 (en) | Vitamin e drop | |
| KR940005274A (en) | Sjoegren Syndrome Treatment | |
| JPH06506212A (en) | Use of riboflavin for the treatment of HIV viral diseases, herpes, retinitis pigmentosa and malaria | |
| WO1991002529A2 (en) | Product and method for killing abnormal vertebrate cells | |
| HUP0001268A2 (en) | Use of sodium channel blocker in the formulation of a medicament for preventing optic nerve degeneration associated with glaucoma | |
| KR960003729A (en) | Drugs with antihyperglycemic action | |
| FR2712809B1 (en) | New pharmaceutical composition intended for the preparation of a stable powder containing, as active ingredient, a combination of acetylsalicylic acid and metoclopramide. | |
| IE71171B1 (en) | Use of lithium in the treatment or prophylaxis of mollescum contagiosum | |
| US5246964A (en) | Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters | |
| JP3050898B2 (en) | Aqueous pharmaceutical preparation | |
| WO1991015200A3 (en) | Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases | |
| KR900701278A (en) | Bile acids for the treatment of viral infections | |
| TH8676B (en) | Pharmaceutical constituents used in the treatment of glaucoma | |
| US6077839A (en) | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists | |
| US6156349A (en) | Method of treating HIV infection with suppository containing mammalian liver extract | |
| TH13559A (en) | Pharmaceutical constituents used in the treatment of glaucoma | |
| FI932654A0 (en) | Hydroxamsyraderivat, som hindrar lipoxigenas |